v3.26.1
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Feb. 12, 2026
Oct. 21, 2025
Nov. 08, 2022
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Stockholders' Deficit              
Common stock, par value         $ 0.0001   $ 0.0001
Net proceeds         $ 53,650    
Sales agreement              
Stockholders' Deficit              
Number of common stock shares sold during the period         0 0  
Common stock remaining available for sales under the ATM Offering         $ 64,900    
Sales agreement | Maximum              
Stockholders' Deficit              
Common stock     $ 92,500        
Private placement              
Stockholders' Deficit              
Number of common stock shares sold during the period   4,634,995          
Class of Warrant or Right, Date from which Warrants or Rights Exercisable   Oct. 21, 2025          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   463,498          
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.01          
Proceeds from Issuance of Private Placement   $ 8,000          
Common stock, net proceeds   $ 7,900          
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date   Oct. 21, 2030          
Exercise shares         0    
Public offering              
Stockholders' Deficit              
Common stock       $ 53,650      
Number of common stock shares sold during the period       32,890,000      
Aggregate shares 28,600,000            
Common stock, par value $ 0.0001            
Share price $ 1.75            
Net proceeds       $ 53,600      
Underwriters' Option to Purchase Additional Shares              
Stockholders' Deficit              
Aggregate shares 4,290,000            
Term of share offering 30 days            
Share price $ 1.645